Replies to post #480017 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

It appears that a P3 with the EMA may be different than a P3 with the FDA.

The EMA P3 could be similar to the P3 required by the FDA for an AA approval i.e. conditional approval that allows the drug to be marketed while the P3 is being run.

Perhaps that is what was being referenced in the PR.